BTAI - BioXcel Therapeutics, Inc.

1.48
-0.130   -8.784%

Share volume: 2,900,127
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$1.61
-0.13
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-09-2024 08-06-2024 11-14-2024 03-28-2025 05-12-2025 08-12-2025 11-12-2025
Total revenue 582.000 K 1.104 M 214.000 K 366.000 K 168.000 K 120.000 K 98.000 K
Cost of revenue 80.000 K 62.000 K 1.170 M 831.000 K 14.000 K 107.000 K 11.000 K
Gross profit 502.000 K 1.042 M -956.000 K -465.000 K 154.000 K 13.000 K 87.000 K
    107.57% -191.75% 51.36% 133.12% -91.56% 569.23%  
Operating expenses 24.665 M 17.482 M 12.784 M 9.996 M 10.253 M 15.865 M 14.121 M
Selling general and admin 13.264 M 9.450 M 7.683 M 4.095 M 5.699 M 5.609 M 5.381 M
Research and development 11.401 M 8.032 M 5.101 M 5.901 M 4.554 M 10.256 M 8.740 M
Total expenses 24.665 M 18.338 M 14.337 M 10.028 M 10.253 M 15.865 M 14.315 M
    -25.65% -21.82% -30.06% 2.24% 54.74% -9.77%  
Operating income -24.163 M -17.296 M -15.293 M -10.493 M -10.099 M -15.852 M -14.228 M
Ebit -24.131 M -5.270 M -10.476 M -7.195 M -3.540 M -15.195 M -26.774 M
Pretax income -26.791 M -8.299 M -13.650 M -10.859 M -7.254 M -19.187 M -30.911 M
    -69.02% 64.48% -20.45% -33.20% 164.50% 61.10%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -26.791 M -8.299 M -13.650 M -10.859 M -7.254 M -19.187 M -30.911 M
    69.02% -64.48% 20.45% 33.20% -164.50% -61.10%